Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the US: A Narrative Review of the Literature

被引:33
作者
Baldwin, Aleta [1 ]
Light, Brenda [2 ]
Allison, Waridibo E. [3 ]
机构
[1] Calif State Univ Sacramento, Dept Publ Hlth, Solano Hall 3014,6000 J St, Sacramento, CA 95819 USA
[2] Univ Texas Austin, Sch Nursing, Austin, TX 78712 USA
[3] Univ Texas Hlth Sci Ctr San Antonio, Div Infect Dis, Dept Med, San Antonio, TX 78229 USA
关键词
HIV prevention; Pre-exposure prophylaxis; Gender; PrEP; Cisgender women; Transgender women; HEALTH-CARE-SYSTEM; NEW-YORK; UNITED-STATES; SAFER CONCEPTION; RISK PERCEPTION; DRUG DETECTION; BLACK-WOMEN; PREVENTION; MEN; SEX;
D O I
10.1007/s10508-020-01903-8
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Using a socioecological approach, this review describes the peer-reviewed literature on oral pre-exposure prophylaxis (PrEP) among both cisgender (cis women) and transgender women (trans women) in the U.S. A search of the PubMed database and HIV-related conference abstracts generated over 2,200 articles and abstracts. Of these, 103 fulfilled review inclusion criteria. Most of the existing research presents findings on individual-level factors associated with PrEP use such as willingness and perceived barriers. There was far less investigation of factors related to PrEP at more distal ecological levels. Though trans women are at greater risk of HIV infection than cisgender women, less is known about this population group with respect to PrEP despite their inclusion in many major clinical trials. Further, the literature is characterized by a persistent conflation of sex and gender which makes it difficult to accurately assess the reviewed research on HIV prevention and PrEP apart from risk group. Informed by these findings, we highlight specific opportunities to improve access to PrEP and reduce socioecological barriers to PrEP care engagement for cisgender and transgender women.
引用
收藏
页码:1713 / 1728
页数:16
相关论文
共 125 条
[1]   Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study [J].
Amico, K. Rivet ;
Mehrotra, Megha ;
Avelino-Silva, Vivian I. ;
McMahan, Vanessa ;
Veloso, Valdilea G. ;
Anderson, Peter ;
Guanira, Juan ;
Grant, Robert .
AIDS AND BEHAVIOR, 2016, 20 (07) :1535-1540
[2]   Study Product Adherence Measurement in the iPrEx Placebo-Controlled Trial: Concordance With Drug Detection [J].
Amico, K. Rivet ;
Marcus, Julia L. ;
McMahan, Vanessa ;
Liu, Albert ;
Koester, Kimberly A. ;
Goicochea, Pedro ;
Anderson, Peter L. ;
Glidden, David ;
Guanira, Juan ;
Grant, Robert .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 66 (05) :530-537
[3]  
[Anonymous], 2012, WILL SHOULD WOMEN US
[4]  
[Anonymous], 2008, INT AIDS C MEX CIT M
[5]  
[Anonymous], 2018, C RETR OPP INF BOST
[6]  
[Anonymous], 2017, HIV SURVEILLANCE REP
[7]   Knowledge, Attitudes, and Likelihood of Pre-Exposure Prophylaxis (PrEP) Use Among US Women at Risk of Acquiring HIV [J].
Auerbach, Judith D. ;
Kinsky, Suzanne ;
Brown, Gina ;
Charles, Vignetta .
AIDS PATIENT CARE AND STDS, 2015, 29 (02) :102-110
[8]   A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective [J].
Bailey, Jennifer L. ;
Molino, Suzanne T. ;
Vega, Ana D. ;
Badowski, Melissa .
INFECTIOUS DISEASES AND THERAPY, 2017, 6 (03) :363-382
[9]   Worldwide burden of HIV in transgender women: a systematic review and meta-analysis [J].
Baral, Stefan D. ;
Poteat, Tonia ;
Stromdahl, Susanne ;
Wirtz, Andrea L. ;
Guadamuz, Thomas E. ;
Beyrer, Chris .
LANCET INFECTIOUS DISEASES, 2013, 13 (03) :214-222
[10]   Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States [J].
Bazzi, Angela R. ;
Leech, Ashley A. ;
Biancarelli, Dea L. ;
Sullivan, Meg ;
Drainoni, Mari-Lynn .
AIDS PATIENT CARE AND STDS, 2017, 31 (08) :348-355